
PRE · NASDAQ
Prenetics Global Limited
$16.20 +0.10 (+0.62%)
Company overview
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing firm. Its products include CircleDNA, a consumer genetic testing product, and Circle HealthPod, a rapid detection health monitoring system that enables users to take COVID-19 tests at point-of-care or at home using nucleic acid amplification testing. The company also offers ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NASDAQ
- Market cap
- $274M
- Employees
- 285
- Headquarters
- Quarry Bay
- Website
- prenetics.com
- CEO
- Sheng Wu Yeung
- Listed
- July 16, 2021
- P/E
- -4.03
- Dividend yield
- 2.46%
Company financials
- Revenue
- $95.1M
- Gross profit
- $50.4M
- Operating income
- -$39.3M
- EBITDA
- -$41M
- Net income
- -$58.3M
- EPS
- -$4.02
- Total assets
- $204M
- Total debt
- $2.2M
- Gross margin
- 52.99%
- Net margin
- -61.32%
- Earnings yield
- -24.80%
No product segmentation.
Showing FY 2025
News